Guidelines for the evaluation of surgical risk in bronchogenic carcinoma;Normativa sobre valoración del riesgo quirúrgico en el carcinoma broncogénico

Archivos de Bronconeumologia

Volumn 41, Issue 12, 2005, Pages 686-697

  Varela Simo G ^a   Barbera Mir J A ^b   Cordovilla Perez R ^a   Duque Medina, J L ^c   Lopez Encuentra A ^d   Puente Maestu, L ^e  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL GAS; COMORBIDITY; HUMAN; LUNG CARCINOMA; LUNG FUNCTION; PRACTICE GUIDELINE; REVIEW; SPIROMETRY; SURGICAL RISK;

EID: 31144472049     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1579-2129(06)60336-4     Document Type: Article

References (127)

1. Grupo Cooperative Médico-Quirúrgico del Carcinoma Bronocogénico del Hospital Universitario 12 de Octubre. Carcinoma broncogénico: algoritmo diagnóstico-terapéutico 2001. Disponible en: http://www.mbeneumología.org
2. López Encuentra A. The Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Criteria of functional and oncological operability in surgery for lung cancer: a multicenter study. Lung Cancer. 1998;20:161-8.
3. López Encuentra A, and Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Comorbidity in lung cancer. A multicenter descriptive study of 2,992 patients. Lung Cancer. 2002;35:263-9.
4. Harpole DH, DeCamp MM, Hur K, et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg. 1999;117:969-79.
5. Varela G, Toledo J. Pulmonary resection for lung cancer in the elderly. En: Peters RM, Toledo J, editores. Perioperative care. Currents topics in general thoracic surgery. An international series. Amsterdam: Elsevier; 1992. p. 160-3.
6. De Perrot M, Licker M, Reymond MA, Robert J, Spiliopoulos A. Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J. 1999;14:419-22.
7. British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56:89-108.
8. Battafarano R, Piccirillo JF, Meyers B, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123:280-7.
9. Wernly JA, DeMeester TR. Preoperative assessment of patients undergoing lung resection for cancer. En: Roth JA, Ruckdeschel JC, Weisenburger TH, editores. Thoracic oncology. 2nd ed. Philadelphia: W.B. Saunders; 1995. p. 104-24.
10. Guadagnoli E, Weitberg A, Mor V, Silliman RA, Glicksman AS, Cummings FJ. The influence of patient age on the diagnosis and treatment of lung and colorectal cancer. Arch Intern Med. 1990;150:1485-90.
11. López Encuentra A, Martínez González del Río J, Pérez Rodríguez E. Datos epidemiológicos en carcinoma broncogénico. Med Clin (Barc). 1979;72:361-8.
12. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica (GCCB-S). La cirugía del carcinoma broncogénico en España. Estudio descriptivo. Arch Bronconeumol. 1995;31:303-9.
13. Aller Álvarez JL, De Frutos Arribas JF, Díez Herranz A, et al. Comorbilidad. En: Grupo de Estudio del Carcinoma Broncopulmonar de SOCALPAR, editores. El carcinoma broncopulmonar en la Comunidad de Castilla y Léon. Año 1997. Madrid: FAES; 2000. p. 81-8.
14. Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica. Ann Thorac Surg. 1997;63:944-50.
15. Belzberg H, Rivkind AI. Preoperative cardiac preparation. Chest. 1999;115 Suppl 5:S82-95.
16. McClave SA, Snider HL, Spain DA. Preoperative issues in clinical nutrition. Chest. 1999;115 Suppl 5:S64-70.
17. Uramato H, Kakahishi R, Fujino Y, et al. Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer. Thorax. 2001;56:59-61.
18. Duque JL, and Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Mortality after pneumonectomy in patients with lung cancer and know cardiac disease. Lung Cancer. 2000;29 Suppl 1:135.
19. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002;105:1257-67.
20. Pastor Torres LF, Antiago Ramírez R, Honorato Pérez JM, Junquera Planas CM, Navarro Salas E, Ortiguera Aso FJ, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en la valoración del riesgo quirúrgico del paciente cardiópata sometido a cirugía no cardíaca. Rev Esp Cardiol. 2001;54:186-93.
21. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000;161:5-8.
22. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med. 1986;105:503-7.
23. Steenland K, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline silica. Am J Epidemiol. 2001;153:695-703.
24. Grupo de Trabajo SEPAR. Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva cronica. Barcelona: Doyma; 2001.
25. 1 tras reseccio¿n pulmonar por carcinoma broncogénico? Arch Bronconeumol. 2001;37 Supl 1:73-4.
26. Korst RJ, Ginsberg RJ, Ailawadi M, et al. Lobectomy improves ventilatory function in selected patients with severe COPD. Ann Thorac Surg. 1998;66:898-902.
27. López Encuentra A, Pozo Rodríguez F, Martín Escribano P, et al. Surgical lung cancer. Risk operative analysis. Lung Cancer. 2004;43:361-2.
28. Santos-García G, Varela G, Novoa N, Jiménez MF. Prediction of postoperative morbidity after lung resection using an artificial neural network ensemble. Artif Intell Med. 2004;30:61-9.
29. Brunelli A, Fianchini A, Gesuita R, Carle F. POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity. Ann Thorac Surg. 1999;67:329-31.
30. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-9.
31. Bernard A, Ferrand L, Hagry O, Benoit L, Cheynel N, Favre JP. Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg. 2000;70:1161-7.
32. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-9.
33. Locke KA. Clinical prediction guide. A simple index predicted cardiac complications in elective major noncardiac surgery. ACP Journal Club: March-April 2000.
34. Gilbert K, Larocque BJ, Patrick LT. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med. 2000;133:356-9.
35. Mittman C. Assessment of operative risk in thoracic surgery. Am Rev Respir Dis. 1961;84:197-207.
36. Nagasaki F, Flehinger BJ, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest. 1982;82:25-9.
37. Olsen GN, Block AJ, Swenson EW, Castle JR, Wynne JW. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis. 1975;111:379-87.
38. Reilly J. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999;116:8474-6.
39. American College of Chest Physicians. Preoperative pulmonary function testing. Ann Intern Med. 1990;112:793-4.
40. Morice RC, Peters EJ, Ryan MB, Putnam JD, Ali MK, Roth JA. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest. 1992;101:356-61.
41. Bolliger CT, Perruchoud AP. Functional evaluation of the lung resection candidate. Eur Respir J. 1998;11:198-212.
42. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection. Chest. 1994;105:753-9.
43. Ribas J. Aplicabilidad de las pruebas de esfuerzo en Neumología. Arch Bronconeumol. 2000;36:44-51.
44. Meléndez JA, Fischer ME. Preoperative pulmonary evaluation of the thoracic surgical patient. Chest Surg Clin North Am. 1997;7:641-54.
45. Miller JI. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg. 1993;105:347-52.
46. Wyser C, Stulz P, Soler M, Tamm M, Muller-Brand J, Habicht J, et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med. 1999;159:1450-6.
47. Bousamra M H, Presberg KW, Chammas JH, Tweddell JS, Winton BL, Bielefeld MR, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62:968-75.
48. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988;96:894-900.
49. Markos J, Mullan BP, Hillman DR, Musk AW, Antico VF, Lovegrove FT, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139:902-10.
50. Ladurie MLR, Ranson-Bitker B. Uncertainties in the expected value for forced expiratory volume in one second after surgery. Chest. 1986;90:222-8.
51. Varela G, Jiménez MF, Novoa N, Aranda JL. Concordancia entre el tipo de resección programada y la efectuada en pacientes con carcinoma pulmonar. Arch Bronconeumol. 2005;41:84-7.
52. Corris PA, Ellis DA, Hawkins T, Gibson GJ. Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. Thorax. 1987;42:285-91.
53. Bolliger CT, Jordan P, Soler M, Stulz P, Gradel E, Skarvan K, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med. 1995;151:1472-80.
54. Puente-Maestu L, Ruiz de Ona JM, Rodríguez-Hermosa JL, Santa-Cruz SA, Tatay E, Cubillo JM. Predicción de la capacidad de esfuerzo tras la resección pulmonar en pacientes con limitación crónica al flujo aéreo. Arch Bronconeumol. 1998;34:473-8.
55. Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med. 1994;947-55.
56. Bolliger CT, Wyser C, Roser H, Soler M, Perruchoud AP. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest. 1995;108:341-8.
57. Ribas J, Díaz O, Barberà JA, Mateu M, Canalis E, Jover L, et al. Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J. 1998;12:1429-35.
58. Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest. 1992;102:1774-9.
59. Tsubota N, Yanagawa M, Yoshimura M, Murotani A, Hatta T. The superiority of exercise testing over spirometry in the evaluation of postoperative lung function for patients with pulmonary disease. Surg Today. 1994;24:103-5.
60. Olsen GN, Bolton JWR, Weiman DS, Haynes JL, Hornung CA, Almond CH. Stair climbing as an exercise test to predict the postoperative complications of lung resection. Chest. 1991;99:587-90.
61. Larsen RK, Svendsen UG, Milman N, Brenoe J, Petersen BN. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J. 1997;10:1559-65.
62. Smith TP, Kinasewitz GT, Tucker WY, Spillers WP, George RB. Exercise capacity as predictor of post-thoracotomy morbidity. Am Rev Respir Dis. 1984;129:730-4.
63. Torchio R, Gulotta C, Parvis M, Pozzi R, Giardino R, Borasio P, et al. Gas exchange threshold as a predictor of severe postoperative complications after lung resection in mild-to-moderate chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1998;53:127-33.
64. Puente Maestu L, Rodríguez Hermosa JL, Ruiz de Ona JM, Santa-Cruz Seminiani A, De Lucas Ramos P, García de Pedro J, et al. Papel de la estimación preoperatoria de la captación máxima de oxígeno en la predicción de insuficiencia cardiorrespiratoria en el período postoperatorio inmediato en la cirugía torácica. Arch Bronconeumol. 1998;34:127-32.
65. Colman NC, Schraufnagel DE, Rivington RN, Pardy RL. Exercise testing in the evaluation of patients for lung resection. Ann Thorac Surg. 1987;44:344-9.
66. Boysen PG, Clark CA, Block AJ. Graded exercise testing and post-thoracotomy complications. J Cardiothorac Anesth. 1990;4:68-72.
67. Bolliger CT, Soler M, Stulz P, Gradel E, Muller-Brand J, Elsasser S, et al. Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients. Respiration. 1994;61:181-6.
68. Pate P, Tenholder MF, Griffin JP, Eastridge CE, Weiman DS. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg. 1996;61:1494-500.
69. Walsh GL, Morice RC, Putnam JB, Nesbitt JC, McMurtrey MJ, Ryan B, et al. Resection of lung cancer is justified in high risk patients selected by exercise oxygen consumption. Ann Thorac Surg. 1994;58:704-11.
70. Miyoshi S, Nakahara K, Ohno K, Monden Y, Kawashima Y. Exercise tolerance test in lung cancer patients: the relationship between exercise capacity and posthoracotomy hospital mortality. Ann Thorax Surg. 1987;44:487-90.
71. Okada M, Okada M, Ishii N, Yamashita C, Sugimoto T, Okada K, et al. Right ventricular ejection fraction in the preoperative risk evaluation of candidates for pulmonary resection. J Thorac Cardiovasc Surg. 1996;112:364-70.
72. Nakagawa K, Nakahara K, Miyoshi S, Kawashima Y. Oxygen transport during incremental exercise load as predictor of operative risk in lung cancer patients. Chest. 1992;101:1369-75.
73. Rendina EA, De Giacomo T, Venuta F, Ciccone AM, Coloni GF. Lung conservation techniques: bronchial sleeve resection and reconstruction of the pulmonary artery. Semin Surg Oncol. 2000;18:165-72.
74. Olsen GN, Wiman DS, Bolton JWR, Gass D, McLain WC, Schoonover GA, et al. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation of tolerance to lung resection. Chest. 1989;95:267-73.
75. Varela G, Cordovilla R, Jiménez MF, Novoa N. Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection. Eur J Cardiothorac Surg. 2001;19:351-4.
76. Von Dossow V, Welte M, Zaune U, Martin E, Walter M, Ruckert J, et al. Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery. Anesth Analg. 2001;92:848-54.
77. 2. Anesth Analg. 2000;90:35-41.
78. Varela G, Del Barrio E, Jiménez M, García Cosmes P, Criado M, López Novoa JM. Papel del óxido nítrico en la adaptación del lecho vascular pulmonar a la ventilación unilateral durante intervenciones torácicas. Arch Bronconeumol. 1998;34:194-8.
79. Mascotto G, Bizzarri M, Messina M, Cerchierini E, Toni G, Carozzo A, et al. Prospective, randomized, controlled evaluation of the preventive effects of positive end-expiratory pressure on patient oxygenation during one-lung ventilation. Eur J Anaesthesiol. 2003;20:704-10.
80. Craig SR, Leaver HA, Yap PL, Pugh GC, Walker WS. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg. 2001;20:455-63.
81. Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure. Ann Thorac Surg. 2001;72:362-5.
82. Yim AP, Wan S, Lee TW, Arifi AA. VATS lobectomy reduces cytokine responses compared with conventional surgery. Ann Thorac Surg. 2000;70:243-7.
83. Kaseda S, Aoki T, Hangai N, Shimizu K. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg. 2000;70:1644-6.
84. Nakata M, Saeki H, Yokoyama N, Kurita A, Takiyama W, Takashima S. Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg. 2000;70:938-41.
85. Kirby TJ, Mack MJ, Landreneau RJ, Rice TW. Lobectomy - video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg. 1995;109:997-1001.
86. Landreneau RJ, Pigula F, Luketich JD, Keenan RJ, Hartley S, Fetterman LS, et al. Acute and chronic morbidity differences between muscle-sparing and standard lateral thoracotomies. J Thorac Cardiovasc Surg. 1996;112:1346-50.
87. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996;9:7-10.
88. 0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-2.
89. Sekine Y, Iwata T, Chiyo M, Yasufuku K, Motohashi S, Yoshida S, et al. Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease. Ann Thorac Surg. 2003;76:356-62.
90. Keenan RJ, Landreneau RJ, Maley RH Jr, Singh D, Macherey R, Bartley S, et al. Segmental resection spares pulmonary function in patients with stage 1 lung cancer. Ann Thorac Surg. 2004;78:228-33.
91. Licker M, De Perrot M, Hohn L, Tschopp JM, Robert J, Frey JG, et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg. 1999;15:314-9.
92. Wada H, Nakamura T, Nakamoto K, Maeda M, Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg. 1998;115:70-3.
93. Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997;11:445-9.
94. Breyer RH, Zippe C, Pharr WF, Jensik RJ, Kittle CF, Faber LP. Thoracotomy in patients over age seventy years: ten-year experience. J Thorac Cardiovasc Surg. 1981;81:187-93.
95. Weiss W. Operative mortality and five-year survival rates in men with bronchogenic carcinoma. Chest. 1974;66:483-7.
96. Wahi R, McMurtrey MJ, DeCaro LF, Mountain CF, Ali MK, Smith TL, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989;48:33-7.
97. Klemperer J, Ginsberg RJ. Morbidity and mortality after pneumonectomy. Chest Surg Clin N Am. 1999;9:515-25.
98. Wright CD, Wain JC, Mathisen DJ, Grillo HC. Postpneumonectomy bronchopleural fistula after sutured bronchial closure: incidence, risk factors, and management. J Thorac Cardiovasc Surg. 1996;112:1367-71.
99. De Perrot M, Licker M, Robert J, Spiliopoulos A. Incidence, risk factors and management of bronchopleural fistulae after pneumonectomy. Scand Cardiovasc J. 1999;33:171-4.
100. Jalal A, Jeyasingham K. Bronchoplasty for malignant and benign conditions: a retrospective study of 44 cases. Eur J Cardiothorac Surg. 2000;17:370-6.
101. Kruger M, Uschinsky K, Hassler K, Engelmann C. Postoperative complications after bronchoplastic procedures in the treatment of bronchial malignancies. Eur J Cardiothorac Surg. 1998;14:46-52.
102. Suen HC, Meyers BF, Guthrie T, Pohl MS, Sundaresan S, Roper CL, et al. Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg. 1999;67:1557-62.
103. Yoshino I, Yokoyama H, Yano T, Ueda T, Takai E, Mizutani K, et al. Comparison of the surgical results of lobectomy with bronchoplasty and pneumonectomy for lung cancer. J Surg Oncol. 1997;64:32-5.
104. Tedder M, Anstadt MP, Tedder SD, Lowe JE. Current morbidity, mortality, and survival after bronchoplastic procedures for malignancy. Ann Thorac Surg. 1992;54:387-91.
105. Kodama K, Higashiyama M, Yokouchi H, Takami K, Yasuda T, Kabuto T. Survival and postoperative complications after extended surgery for non-small-cell lung cancer. A retrospective study. Jpn J Thorac Cardiovasc Surg. 1999;47:546-51.
106. Pairolero PC, Trastek VF, Payne WS. Treatment of bronchogenic carcinoma with chest wall invasion. Surg Clin North Am. 1987;67:959-64.
107. Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest. 1994;105:760-6.
108. Hsia CCW, Peshock RM, Estrera AS, McIntire DD, Ramanathan M. Respiratory muscle limitation in patients after pneumonectomy. Am Rev Respir Dis. 1993;147:744-52.
109. Maeda H, Nakahara K, Ohno K, Kido T, Ikeda M, Kawashima Y. Diaphragm function after pulmonary resection: relationship to postoperative respiratory failure. Am Rev Respir Dis. 1988;137:678-81.
110. Jones JG, Sapsford DJ, Wheatley RG. Postoperative hypoxaemia: mechanisms and time course. Anaesthesia. 1990;45:566-73.
111. Nomori H, Horio H, Fuyuno G, Kobayashi R, Yashima H. Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy. Eur J Cardiothorac Surg. 1996;10:352-8.
112. Watkins WD, Lumb PD. Efectos perioperatorios de la anestesia en atención del paciente quirúrgico. Vol. 2. México D.F.: Ed. Científica Médica Latinoamericana; 1991. p. 6.
113. Aldren CP, Barr LC, Leach RD. Hypoxaemia and postoperative pulmonary complications. Br J Surg. 1991;78:1307-8.
114. Entwistle MD, Roe PG, Sapsford DJ, Berrisford RG, Jones JG. Patterns of oxygenation after thoracotomy. Br J Anaesthesia. 1991;67:704-11.
115. Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson BI, Timmermans C. The effect of incentive spirometry on postoperative pulmonary complications: a systematic review. Chest. 2001;120:971-8.
116. Weiner P, Man A, Weiner M, Rabner M, Waizman J, Magadle R, et al. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection. J Thorac Cardiovasc Surg. 1997;113:552-7.
117. Duque Medina JL. Edema pulmonar postneumonectomía. En: Ramos G, editor. Complicaciones en cirugía torácica. Valladolid: Universidad de Valladolid. Secretariado de Publicaciones e Intercambio internacional; 2002. p. 17-22.
118. Duogenis D, Patrinou V, Filos KS, et al. Blood use in lung resection for carcinoma: perioperative elective anaemia does not compromise the early outcome. Eur J Cardiothorac Surg. 2001;20:372-7.
119. Stehling L, Luban NLC, Anderson KC, et al. Guidelines for blood utilization review. Transfusion. 1994;34:438-48.
120. Hebert P, Wells G, Blajchman MA, et al. Canadian critical care trials group. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409-17.
121. Karmakar MK. Thoracic paravertebral block. Anesthesiology. 2001;95:771-80.
122. Covino BG. Interpleural regional anesthesia [editorial]. Anesth Analg. 1987;67:427-9.
123. Aldrich TK, Prezant DJ. Adverse effects of drugs on the respiratory muscles. Clinics in Chest Medicine. 1990;11:177-89.
124. Ginsberg RJ. Multimodality therapy for stage III N2 lung cancer. An overview. Chest. 1993;103:356S-9S.
125. Doddoli C, Thomas P, Thirion X, et al. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg. 2001;20:385-90.
126. Novoa N, Varela G, Jiménez MF. Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy. Eur J Cardiothorac Surg. 2001;20:700-4.
127. Leo F, Solli P, Spaggiari L, Veronesi G, De Braud F, Léon ME, et al. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Ann Thorac Surg. 2004;77:260-5.